Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

NCT00033371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

NIH

Sponsor class

Conditions

Colorectal Cancer
Familial Adenomatous Polyposis

Interventions

DRUG: Celecoxib
OTHER: Placebo
DRUG: eflornithine
OTHER: Laboratory biomarker analysis
OTHER: Questionnaire administration

Sponsor

National Cancer Institute (NCI)